Table of Content

1 Sustained Release Injectables Market Overview
1.1 Sustained Release Injectables Product Scope
1.2 Sustained Release Injectables Segment by Type
1.2.1 Global Sustained Release Injectables Sales by Type (2016 & 2021 & 2027)
1.2.2 Naltrexone
1.2.3 Exenatide
1.2.4 Estradiol
1.2.5 Other
1.3 Sustained Release Injectables Segment by Application
1.3.1 Global Sustained Release Injectables Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Diabetes
1.3.3 Leukemia
1.3.4 Acromegaly
1.3.5 Other
1.4 Sustained Release Injectables Market Estimates and Forecasts (2016-2027)
1.4.1 Global Sustained Release Injectables Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Sustained Release Injectables Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Sustained Release Injectables Price Trends (2016-2027)

2 Sustained Release Injectables Estimates and Forecasts by Region
2.1 Global Sustained Release Injectables Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Sustained Release Injectables Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Sustained Release Injectables Sales Market Share by Region (2016-2021)
2.2.2 Global Sustained Release Injectables Revenue Market Share by Region (2016-2021)
2.3 Global Sustained Release Injectables Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Sustained Release Injectables Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Sustained Release Injectables Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Sustained Release Injectables Estimates and Projections (2016-2027)
2.4.2 Europe Sustained Release Injectables Estimates and Projections (2016-2027)
2.4.3 China Sustained Release Injectables Estimates and Projections (2016-2027)
2.4.4 Japan Sustained Release Injectables Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Sustained Release Injectables Estimates and Projections (2016-2027)
2.4.6 India Sustained Release Injectables Estimates and Projections (2016-2027)
3 Global Sustained Release Injectables Competition Landscape by Players
3.1 Global Top Sustained Release Injectables Players by Sales (2016-2021)
3.2 Global Top Sustained Release Injectables Players by Revenue (2016-2021)
3.3 Global Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sustained Release Injectables as of 2020)
3.4 Global Sustained Release Injectables Average Price by Company (2016-2021)
3.5 Manufacturers Sustained Release Injectables Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Sustained Release Injectables Market Size by Type
4.1 Global Sustained Release Injectables Historic Market Review by Type (2016-2021)
4.1.1 Global Sustained Release Injectables Sales Market Share by Type (2016-2021)
4.1.2 Global Sustained Release Injectables Revenue Market Share by Type (2016-2021)
4.1.3 Global Sustained Release Injectables Price by Type (2016-2021)
4.2 Global Sustained Release Injectables Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Sustained Release Injectables Sales Forecast by Type (2022-2027)
4.2.2 Global Sustained Release Injectables Revenue Forecast by Type (2022-2027)
4.2.3 Global Sustained Release Injectables Price Forecast by Type (2022-2027)
5 Global Sustained Release Injectables Market Size by Application
5.1 Global Sustained Release Injectables Historic Market Review by Application (2016-2021)
5.1.1 Global Sustained Release Injectables Sales Market Share by Application (2016-2021)
5.1.2 Global Sustained Release Injectables Revenue Market Share by Application (2016-2021)
5.1.3 Global Sustained Release Injectables Price by Application (2016-2021)
5.2 Global Sustained Release Injectables Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Sustained Release Injectables Sales Forecast by Application (2022-2027)
5.2.2 Global Sustained Release Injectables Revenue Forecast by Application (2022-2027)
5.2.3 Global Sustained Release Injectables Price Forecast by Application (2022-2027)

6 North America Sustained Release Injectables Market Facts & Figures
6.1 North America Sustained Release Injectables Sales by Company
6.1.1 North America Sustained Release Injectables Sales by Company (2016-2021)
6.1.2 North America Sustained Release Injectables Revenue by Company (2016-2021)
6.2 North America Sustained Release Injectables Sales Breakdown by Type
6.2.1 North America Sustained Release Injectables Sales Breakdown by Type (2016-2021)
6.2.2 North America Sustained Release Injectables Sales Breakdown by Type (2022-2027)
6.3 North America Sustained Release Injectables Sales Breakdown by Application
6.3.1 North America Sustained Release Injectables Sales Breakdown by Application (2016-2021)
6.3.2 North America Sustained Release Injectables Sales Breakdown by Application (2022-2027)

7 Europe Sustained Release Injectables Market Facts & Figures
7.1 Europe Sustained Release Injectables Sales by Company
7.1.1 Europe Sustained Release Injectables Sales by Company (2016-2021)
7.1.2 Europe Sustained Release Injectables Revenue by Company (2016-2021)
7.2 Europe Sustained Release Injectables Sales Breakdown by Type
7.2.1 Europe Sustained Release Injectables Sales Breakdown by Type (2016-2021)
7.2.2 Europe Sustained Release Injectables Sales Breakdown by Type (2022-2027)
7.3 Europe Sustained Release Injectables Sales Breakdown by Application
7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)

8 China Sustained Release Injectables Market Facts & Figures
8.1 China Sustained Release Injectables Sales by Company
8.1.1 China Sustained Release Injectables Sales by Company (2016-2021)
8.1.2 China Sustained Release Injectables Revenue by Company (2016-2021)
8.2 China Sustained Release Injectables Sales Breakdown by Type
8.2.1 China Sustained Release Injectables Sales Breakdown by Type (2016-2021)
8.2.2 China Sustained Release Injectables Sales Breakdown by Type (2022-2027)
8.3 China Sustained Release Injectables Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Sustained Release Injectables Market Facts & Figures
9.1 Japan Sustained Release Injectables Sales by Company
9.1.1 Japan Sustained Release Injectables Sales by Company (2016-2021)
9.1.2 Japan Sustained Release Injectables Revenue by Company (2016-2021)
9.2 Japan Sustained Release Injectables Sales Breakdown by Type
9.2.1 Japan Sustained Release Injectables Sales Breakdown by Type (2016-2021)
9.2.2 Japan Sustained Release Injectables Sales Breakdown by Type (2022-2027)
9.3 Japan Sustained Release Injectables Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Sustained Release Injectables Market Facts & Figures
10.1 Southeast Asia Sustained Release Injectables Sales by Company
10.1.1 Southeast Asia Sustained Release Injectables Sales by Company (2016-2021)
10.1.2 Southeast Asia Sustained Release Injectables Revenue by Company (2016-2021)
10.2 Southeast Asia Sustained Release Injectables Sales Breakdown by Type
10.2.1 Southeast Asia Sustained Release Injectables Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Sustained Release Injectables Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Sustained Release Injectables Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Sustained Release Injectables Market Facts & Figures
11.1 India Sustained Release Injectables Sales by Company
11.1.1 India Sustained Release Injectables Sales by Company (2016-2021)
11.1.2 India Sustained Release Injectables Revenue by Company (2016-2021)
11.2 India Sustained Release Injectables Sales Breakdown by Type
11.2.1 India Sustained Release Injectables Sales Breakdown by Type (2016-2021)
11.2.2 India Sustained Release Injectables Sales Breakdown by Type (2022-2027)
11.3 India Sustained Release Injectables Sales Breakdown by Application
11.3.1 India Sustained Release Injectables Sales Breakdown by Application (2016-2021)
11.3.2 India Sustained Release Injectables Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Sustained Release Injectables Business
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Business Overview
12.1.3 AstraZeneca Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Sustained Release Injectables Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Corporation Information
12.2.2 Eli Lilly Business Overview
12.2.3 Eli Lilly Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eli Lilly Sustained Release Injectables Products Offered
12.2.5 Eli Lilly Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Business Overview
12.3.3 Sanofi Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Sustained Release Injectables Products Offered
12.3.5 Sanofi Recent Development
12.4 Roche
12.4.1 Roche Corporation Information
12.4.2 Roche Business Overview
12.4.3 Roche Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Roche Sustained Release Injectables Products Offered
12.4.5 Roche Recent Development
12.5 Novartis
12.5.1 Novartis Corporation Information
12.5.2 Novartis Business Overview
12.5.3 Novartis Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Novartis Sustained Release Injectables Products Offered
12.5.5 Novartis Recent Development
12.6 Aurobindo
12.6.1 Aurobindo Corporation Information
12.6.2 Aurobindo Business Overview
12.6.3 Aurobindo Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Aurobindo Sustained Release Injectables Products Offered
12.6.5 Aurobindo Recent Development
12.7 Avadel
12.7.1 Avadel Corporation Information
12.7.2 Avadel Business Overview
12.7.3 Avadel Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Avadel Sustained Release Injectables Products Offered
12.7.5 Avadel Recent Development
12.8 Biomarin
12.8.1 Biomarin Corporation Information
12.8.2 Biomarin Business Overview
12.8.3 Biomarin Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Biomarin Sustained Release Injectables Products Offered
12.8.5 Biomarin Recent Development
12.9 Camurus
12.9.1 Camurus Corporation Information
12.9.2 Camurus Business Overview
12.9.3 Camurus Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Camurus Sustained Release Injectables Products Offered
12.9.5 Camurus Recent Development
12.10 Critical Pharmaceuticals
12.10.1 Critical Pharmaceuticals Corporation Information
12.10.2 Critical Pharmaceuticals Business Overview
12.10.3 Critical Pharmaceuticals Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Critical Pharmaceuticals Sustained Release Injectables Products Offered
12.10.5 Critical Pharmaceuticals Recent Development
12.11 Alkermes
12.11.1 Alkermes Corporation Information
12.11.2 Alkermes Business Overview
12.11.3 Alkermes Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Alkermes Sustained Release Injectables Products Offered
12.11.5 Alkermes Recent Development
12.12 Amylin
12.12.1 Amylin Corporation Information
12.12.2 Amylin Business Overview
12.12.3 Amylin Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Amylin Sustained Release Injectables Products Offered
12.12.5 Amylin Recent Development
12.13 Ascendis Pharma
12.13.1 Ascendis Pharma Corporation Information
12.13.2 Ascendis Pharma Business Overview
12.13.3 Ascendis Pharma Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Ascendis Pharma Sustained Release Injectables Products Offered
12.13.5 Ascendis Pharma Recent Development
12.14 Taiwan Liposome Company
12.14.1 Taiwan Liposome Company Corporation Information
12.14.2 Taiwan Liposome Company Business Overview
12.14.3 Taiwan Liposome Company Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Taiwan Liposome Company Sustained Release Injectables Products Offered
12.14.5 Taiwan Liposome Company Recent Development

13 Sustained Release Injectables Manufacturing Cost Analysis
13.1 Sustained Release Injectables Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Sustained Release Injectables
13.4 Sustained Release Injectables Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Sustained Release Injectables Distributors List
14.3 Sustained Release Injectables Customers

15 Market Dynamics
15.1 Sustained Release Injectables Market Trends
15.2 Sustained Release Injectables Drivers
15.3 Sustained Release Injectables Market Challenges
15.4 Sustained Release Injectables Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Sustained Release Injectables Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Sustained Release Injectables Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Sustained Release Injectables Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Sustained Release Injectables Sales (K Units) by Region (2016-2021)
Table 5. Global Sustained Release Injectables Sales Market Share by Region (2016-2021)
Table 6. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Sustained Release Injectables Revenue Share by Region (2016-2021)
Table 8. Global Sustained Release Injectables Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Sustained Release Injectables Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Sustained Release Injectables Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Sustained Release Injectables Revenue Share Forecast by Region (2022-2027)
Table 12. Global Sustained Release Injectables Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Sustained Release Injectables Sales Share by Company (2016-2021)
Table 14. Global Sustained Release Injectables Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Sustained Release Injectables Revenue Share by Company (2016-2021)
Table 16. Global Sustained Release Injectables by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sustained Release Injectables as of 2020)
Table 17. Global Sustained Release Injectables Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Sustained Release Injectables Manufacturing Sites and Area Served
Table 19. Manufacturers Sustained Release Injectables Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Sustained Release Injectables Sales (K Units) by Type (2016-2021)
Table 22. Global Sustained Release Injectables Sales Share by Type (2016-2021)
Table 23. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Sustained Release Injectables Price (USD/Unit) by Type (2016-2021)
Table 25. Global Sustained Release Injectables Sales Share by Type (2022-2027)
Table 26. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Sustained Release Injectables Revenue Share by Type (2022-2027)
Table 28. Global Sustained Release Injectables Price (USD/Unit) by Type (2022-2027)
Table 29. Global Sustained Release Injectables Sales (K Units) by Application (2016-2021)
Table 30. Global Sustained Release Injectables Sales Share by Application (2016-2021)
Table 31. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Sustained Release Injectables Price (USD/Unit) by Application (2016-2021)
Table 33. Global Sustained Release Injectables Sales (K Units) by Application (2022-2027)
Table 34. Global Sustained Release Injectables Sales Share by Application (2022-2027)
Table 35. Global Sustained Release Injectables Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Sustained Release Injectables Revenue Share by Application (2022-2027)
Table 37. Global Sustained Release Injectables Price (USD/Unit) by Application (2022-2027)
Table 38. North America Sustained Release Injectables Sales (K Units) by Company (2016-2021)
Table 39. North America Sustained Release Injectables Sales Market Share by Company (2016-2021)
Table 40. North America Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Sustained Release Injectables Revenue Market Share by Company (2016-2021)
Table 42. North America Sustained Release Injectables Sales by Type (2016-2021) & (K Units)
Table 43. North America Sustained Release Injectables Sales Market Share by Type (2016-2021)
Table 44. North America Sustained Release Injectables Sales by Type (2022-2027) & (K Units)
Table 45. North America Sustained Release Injectables Sales Market Share by Type (2022-2027)
Table 46. North America Sustained Release Injectables Sales by Application (2016-2021) & (K Units)
Table 47. North America Sustained Release Injectables Sales Market Share by Application (2016-2021)
Table 48. North America Sustained Release Injectables Sales by Application (2022-2027) & (K Units)
Table 49. North America Sustained Release Injectables Sales Market Share by Application (2022-2027)
Table 50. Europe Sustained Release Injectables Sales (K Units) by Company (2016-2021)
Table 51. Europe Sustained Release Injectables Sales Market Share by Company (2016-2021)
Table 52. Europe Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Sustained Release Injectables Revenue Market Share by Company (2016-2021)
Table 54. Europe Sustained Release Injectables Sales by Type (2016-2021) & (K Units)
Table 55. Europe Sustained Release Injectables Sales Market Share by Type (2016-2021)
Table 56. Europe Sustained Release Injectables Sales by Type (2022-2027) & (K Units)
Table 57. Europe Sustained Release Injectables Sales Market Share by Type (2022-2027)
Table 58. Europe Sustained Release Injectables Sales by Application (2016-2021) & (K Units)
Table 59. Europe Sustained Release Injectables Sales Market Share by Application (2016-2021)
Table 60. Europe Sustained Release Injectables Sales by Application (2022-2027) & (K Units)
Table 61. Europe Sustained Release Injectables Sales Market Share by Application (2022-2027)
Table 62. China Sustained Release Injectables Sales (K Units) by Company (2016-2021)
Table 63. China Sustained Release Injectables Sales Market Share by Company (2016-2021)
Table 64. China Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Sustained Release Injectables Revenue Market Share by Company (2016-2021)
Table 66. China Sustained Release Injectables Sales by Type (2016-2021) & (K Units)
Table 67. China Sustained Release Injectables Sales Market Share by Type (2016-2021)
Table 68. China Sustained Release Injectables Sales by Type (2022-2027) & (K Units)
Table 69. China Sustained Release Injectables Sales Market Share by Type (2022-2027)
Table 70. China Sustained Release Injectables Sales by Application (2016-2021) & (K Units)
Table 71. China Sustained Release Injectables Sales Market Share by Application (2016-2021)
Table 72. China Sustained Release Injectables Sales by Application (2022-2027) & (K Units)
Table 73. China Sustained Release Injectables Sales Market Share by Application (2022-2027)
Table 74. Japan Sustained Release Injectables Sales (K Units) by Company (2016-2021)
Table 75. Japan Sustained Release Injectables Sales Market Share by Company (2016-2021)
Table 76. Japan Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Sustained Release Injectables Revenue Market Share by Company (2016-2021)
Table 78. Japan Sustained Release Injectables Sales by Type (2016-2021) & (K Units)
Table 79. Japan Sustained Release Injectables Sales Market Share by Type (2016-2021)
Table 80. Japan Sustained Release Injectables Sales by Type (2022-2027) & (K Units)
Table 81. Japan Sustained Release Injectables Sales Market Share by Type (2022-2027)
Table 82. Japan Sustained Release Injectables Sales by Application (2016-2021) & (K Units)
Table 83. Japan Sustained Release Injectables Sales Market Share by Application (2016-2021)
Table 84. Japan Sustained Release Injectables Sales by Application (2022-2027) & (K Units)
Table 85. Japan Sustained Release Injectables Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Sustained Release Injectables Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Sustained Release Injectables Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Sustained Release Injectables Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Sustained Release Injectables Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Sustained Release Injectables Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Sustained Release Injectables Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Sustained Release Injectables Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Sustained Release Injectables Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Sustained Release Injectables Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Sustained Release Injectables Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Sustained Release Injectables Sales Market Share by Application (2022-2027)
Table 98. India Sustained Release Injectables Sales (K Units) by Company (2016-2021)
Table 99. India Sustained Release Injectables Sales Market Share by Company (2016-2021)
Table 100. India Sustained Release Injectables Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Sustained Release Injectables Revenue Market Share by Company (2016-2021)
Table 102. India Sustained Release Injectables Sales by Type (2016-2021) & (K Units)
Table 103. India Sustained Release Injectables Sales Market Share by Type (2016-2021)
Table 104. India Sustained Release Injectables Sales by Type (2022-2027) & (K Units)
Table 105. India Sustained Release Injectables Sales Market Share by Type (2022-2027)
Table 106. India Sustained Release Injectables Sales by Application (2016-2021) & (K Units)
Table 107. India Sustained Release Injectables Sales Market Share by Application (2016-2021)
Table 108. India Sustained Release Injectables Sales by Application (2022-2027) & (K Units)
Table 109. India Sustained Release Injectables Sales Market Share by Application (2022-2027)
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. AstraZeneca Sustained Release Injectables Product
Table 114. AstraZeneca Recent Development
Table 115. Eli Lilly Corporation Information
Table 116. Eli Lilly Description and Business Overview
Table 117. Eli Lilly Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Eli Lilly Sustained Release Injectables Product
Table 119. Eli Lilly Recent Development
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Sanofi Sustained Release Injectables Product
Table 124. Sanofi Recent Development
Table 125. Roche Corporation Information
Table 126. Roche Description and Business Overview
Table 127. Roche Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Roche Sustained Release Injectables Product
Table 129. Roche Recent Development
Table 130. Novartis Corporation Information
Table 131. Novartis Description and Business Overview
Table 132. Novartis Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Novartis Sustained Release Injectables Product
Table 134. Novartis Recent Development
Table 135. Aurobindo Corporation Information
Table 136. Aurobindo Description and Business Overview
Table 137. Aurobindo Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Aurobindo Sustained Release Injectables Product
Table 139. Aurobindo Recent Development
Table 140. Avadel Corporation Information
Table 141. Avadel Description and Business Overview
Table 142. Avadel Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Avadel Sustained Release Injectables Product
Table 144. Avadel Recent Development
Table 145. Biomarin Corporation Information
Table 146. Biomarin Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Biomarin Description and Business Overview
Table 148. Biomarin Sustained Release Injectables Product
Table 149. Biomarin Recent Development
Table 150. Camurus Corporation Information
Table 151. Camurus Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Camurus Description and Business Overview
Table 153. Camurus Sustained Release Injectables Product
Table 154. Camurus Recent Development
Table 155. Critical Pharmaceuticals Corporation Information
Table 156. Critical Pharmaceuticals Description and Business Overview
Table 157. Critical Pharmaceuticals Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Critical Pharmaceuticals Sustained Release Injectables Product
Table 159. Critical Pharmaceuticals Recent Development
Table 160. Alkermes Corporation Information
Table 161. Alkermes Description and Business Overview
Table 162. Alkermes Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Alkermes Sustained Release Injectables Product
Table 164. Alkermes Recent Development
Table 165. Amylin Corporation Information
Table 166. Amylin Description and Business Overview
Table 167. Amylin Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Amylin Sustained Release Injectables Product
Table 169. Amylin Recent Development
Table 170. Ascendis Pharma Corporation Information
Table 171. Ascendis Pharma Description and Business Overview
Table 172. Ascendis Pharma Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. Ascendis Pharma Sustained Release Injectables Product
Table 174. Ascendis Pharma Recent Development
Table 175. Taiwan Liposome Company Corporation Information
Table 176. Taiwan Liposome Company Description and Business Overview
Table 177. Taiwan Liposome Company Sustained Release Injectables Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 178. Taiwan Liposome Company Sustained Release Injectables Product
Table 179. Taiwan Liposome Company Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Sustained Release Injectables Distributors List
Table 183. Sustained Release Injectables Customers List
Table 184. Sustained Release Injectables Market Trends
Table 185. Sustained Release Injectables Market Drivers
Table 186. Sustained Release Injectables Market Challenges
Table 187. Sustained Release Injectables Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Sustained Release Injectables Product Picture
Figure 2. Global Sustained Release Injectables Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Sustained Release Injectables Sales Market Share by Application in 2021 & 2027
Figure 6. Diabetes Examples
Figure 7. Leukemia Examples
Figure 8. Acromegaly Examples
Figure 9. Other Examples
Figure 10. Global Sustained Release Injectables Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Sustained Release Injectables Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Sustained Release Injectables Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Sustained Release Injectables Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 14. Global Sustained Release Injectables Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Sustained Release Injectables Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Sustained Release Injectables Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Sustained Release Injectables Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Sustained Release Injectables Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Sustained Release Injectables Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Sustained Release Injectables Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Sustained Release Injectables Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Sustained Release Injectables Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Sustained Release Injectables Players Market Share by Revenue in Sustained Release Injectables: 2016 & 2020
Figure 29. Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Sustained Release Injectables Revenue Share by Type (2016-2021)
Figure 31. Global Sustained Release Injectables Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Sustained Release Injectables Revenue Share by Application (2016-2021)
Figure 33. Global Sustained Release Injectables Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Sustained Release Injectables Sales Market Share by Type in 2020
Figure 35. North America Sustained Release Injectables Sales Market Share by Application in 2020
Figure 36. Europe Sustained Release Injectables Sales Market Share by Type in 2020
Figure 37. Europe Sustained Release Injectables Sales Market Share by Application in 2020
Figure 38. China Sustained Release Injectables Sales Market Share by Type in 2020
Figure 39. China Sustained Release Injectables Sales Market Share by Application in 2020
Figure 40. Japan Sustained Release Injectables Sales Market Share by Type in 2020
Figure 41. Japan Sustained Release Injectables Sales Market Share by Application in 2020
Figure 42. Southeast Asia Sustained Release Injectables Sales Market Share by Type in 2020
Figure 43. Southeast Asia Sustained Release Injectables Sales Market Share by Application in 2020
Figure 44. India Sustained Release Injectables Sales Market Share by Type in 2020
Figure 45. India Sustained Release Injectables Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Sustained Release Injectables
Figure 48. Manufacturing Process Analysis of Sustained Release Injectables
Figure 49. Sustained Release Injectables Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed